Cross-contamination of a UROtsa stock with T24 cells--molecular comparison of different cell lines and stocks

PloS One
Georg JohnenElke Dopp

Abstract

UROtsa is an authentic, immortalized human urothelial cell line that is used to study the effects of metals and other toxic substances, mostly in the context of bladder cancer carcinogenesis. Unusual properties on the molecular level of a provided UROtsa cell line stock prompted us to verify its identity. UROtsa cell line stocks from different sources were tested on several molecular levels and compared with other cell lines. MicroRNA and mRNA expression was determined by Real-Time PCR. Chromosome numbers were checked and PCR of different regions of the large T-antigen was performed. DNA methylation of RARB, PGR, RASSF1, CDH1, FHIT, ESR1, C1QTNF6, PTGS2, SOCS3, MGMT, and LINE1 was analyzed by pyrosequencing and compared with results from the cell lines RT4, T24, HeLa, BEAS-2B, and HepG2. Finally, short tandem repeat (STR) profiling was applied. All tested UROtsa cell line stocks lacked large T-antigen. STR analysis unequivocally identified our main UROtsa stock as the bladder cancer cell line T24, which was different from two authentic UROtsa stocks that served as controls. Analysis of DNA methylation patterns and RNA expression confirmed their differences. Methylation pattern and mRNA expression of the contaminating T24 cell l...Continue Reading

References

Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J M HorowitzR A Weinberg
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D R SengerI U Ali
Aug 15, 1987·International Journal of Cancer. Journal International Du Cancer·U FlatowA S Rabson
May 1, 1973·International Journal of Cancer. Journal International Du Cancer·J BubeníkJ Donner
Jan 1, 1995·Urological Research·J L PetzoldtJ R Masters
Aug 20, 1996·Brain Research. Developmental Brain Research·L BertinoF Nicoletti
Oct 3, 1999·International Journal of Cancer. Journal International Du Cancer·R A MacLeodH G Drexler
Sep 21, 2001·Environmental Health Perspectives·M R RossiD A Sens
Oct 9, 2002·The American Journal of Pathology·Marshall J UristCarlos Cordon-Cardo
Feb 21, 2003·International Journal of Cancer. Journal International Du Cancer·Michael W Y ChanKa Fai To
Feb 21, 2004·Toxicological Sciences : an Official Journal of the Society of Toxicology·Donald A SensSeema Somji
Apr 17, 2004·Traffic·Gerard Apodaca
Sep 7, 2004·Journal of Materials Science. Materials in Medicine·S D ScrivenJ Southgate
Jan 11, 2005·In Vitro Cellular & Developmental Biology. Animal·Gertrude Case BuehringMichael J Eby
Nov 8, 2005·Cancer Genetics and Cytogenetics·M S KimR H Jensen
Dec 7, 2005·The Journal of Cell Biology·Feng-Xia LiangTung-Tien Sun
Dec 22, 2005·Nature Reviews. Genetics·Andrew P FeinbergSteven Henikoff
Oct 26, 2007·International Journal of Cancer. Journal International Du Cancer·Marc Lacroix
May 2, 2008·Carcinogenesis·Taylor J JensenBernard W Futscher
Oct 10, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mariana BraitMohammad Obaidul Hoque
Nov 13, 2008·Cytotechnology·John R Masters
Apr 3, 2009·Kidney International·Xue-Ru WuTung-Tien Sun
Apr 21, 2009·The Journal of Urology·Edmund ChiongH Barton Grossman
May 8, 2009·Epigenetics : Official Journal of the DNA Methylation Society·Ana AparicioJean-Pierre Issa
May 16, 2009·Melanoma Research·Carmen S TellezJean-Pierre J Issa
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Liana AdamColin Dinney
Oct 27, 2009·International Journal of Cancer. Journal International Du Cancer·R Ian Freshney
Oct 28, 2009·International Journal of Cancer. Journal International Du Cancer·Wilhelm G DirksHiroshi Mizusawa

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
methylation profiling

Software Mentioned

RQ manager
Genemapper
ABI TaqMan SDS
UROtsa

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.